nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Taste metallic—Metformin—polycystic ovary syndrome	0.0686	0.197	CcSEcCtD
Gallamine Triethiodide—Upset stomach—Metformin—polycystic ovary syndrome	0.0333	0.0956	CcSEcCtD
Gallamine Triethiodide—Blood disorder—Metformin—polycystic ovary syndrome	0.0261	0.075	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0145	0.0415	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0142	0.0407	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0131	0.0377	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Metformin—polycystic ovary syndrome	0.011	0.0315	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0109	0.0313	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Metformin—polycystic ovary syndrome	0.0102	0.0294	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0102	0.0292	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00934	0.0268	CcSEcCtD
Gallamine Triethiodide—Malaise—Metformin—polycystic ovary syndrome	0.0086	0.0247	CcSEcCtD
Gallamine Triethiodide—Chest pain—Metformin—polycystic ovary syndrome	0.00812	0.0233	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00806	0.0232	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00762	0.0219	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Metformin—polycystic ovary syndrome	0.00756	0.0217	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00709	0.0204	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00699	0.0201	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00672	0.0193	CcSEcCtD
Gallamine Triethiodide—Fatigue—Metformin—polycystic ovary syndrome	0.00671	0.0193	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00642	0.0184	CcSEcCtD
Gallamine Triethiodide—Urticaria—Metformin—polycystic ovary syndrome	0.00618	0.0178	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00615	0.0177	CcSEcCtD
Gallamine Triethiodide—CHRM2—Monoamine GPCRs—ADRB2—polycystic ovary syndrome	0.00599	0.0092	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00599	0.00919	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—FSHR—polycystic ovary syndrome	0.0056	0.00859	CbGpPWpGaD
Gallamine Triethiodide—Asthenia—Metformin—polycystic ovary syndrome	0.00559	0.016	CcSEcCtD
Gallamine Triethiodide—Pruritus—Metformin—polycystic ovary syndrome	0.00551	0.0158	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00533	0.0153	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00529	0.00812	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Amine ligand-binding receptors—ADRB2—polycystic ovary syndrome	0.00504	0.00773	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.005	0.00767	CbGpPWpGaD
Gallamine Triethiodide—Vomiting—Metformin—polycystic ovary syndrome	0.00495	0.0142	CcSEcCtD
Gallamine Triethiodide—Rash—Metformin—polycystic ovary syndrome	0.00491	0.0141	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Metformin—polycystic ovary syndrome	0.0049	0.0141	CcSEcCtD
Gallamine Triethiodide—Headache—Metformin—polycystic ovary syndrome	0.00488	0.014	CcSEcCtD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—ACE—polycystic ovary syndrome	0.00484	0.00743	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRA1D—polycystic ovary syndrome	0.00468	0.00719	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.00465	0.00714	CbGpPWpGaD
Gallamine Triethiodide—Nausea—Metformin—polycystic ovary syndrome	0.00462	0.0133	CcSEcCtD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRA1B—polycystic ovary syndrome	0.00456	0.00699	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.0045	0.00691	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—NPB—polycystic ovary syndrome	0.00429	0.00659	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00406	0.00623	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00398	0.00611	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—PTGER3—polycystic ovary syndrome	0.00358	0.0055	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00356	0.00547	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRA1A—polycystic ovary syndrome	0.00345	0.0053	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00345	0.00529	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—INS—polycystic ovary syndrome	0.00344	0.00528	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.00341	0.00524	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.00337	0.00516	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.00332	0.0051	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.00332	0.0051	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.00332	0.0051	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00311	0.00477	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00309	0.00475	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.00308	0.00472	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—DLG4—polycystic ovary syndrome	0.00305	0.00468	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00302	0.00463	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.00301	0.00462	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00294	0.00451	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—BCL2—polycystic ovary syndrome	0.00291	0.00446	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—FGF18—polycystic ovary syndrome	0.00288	0.00443	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00285	0.00437	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00285	0.00437	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00282	0.00432	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00282	0.00432	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00281	0.00432	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00278	0.00427	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00266	0.00409	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—ADRB2—polycystic ovary syndrome	0.00266	0.00409	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—NPB—polycystic ovary syndrome	0.0026	0.00399	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00259	0.00397	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.00258	0.00397	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.00257	0.00394	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.00255	0.00391	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.00255	0.00391	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00252	0.00386	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.00249	0.00381	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00246	0.00378	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00243	0.00373	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.00239	0.00367	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00236	0.00362	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00224	0.00343	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00223	0.00341	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00219	0.00336	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00217	0.00333	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00217	0.00333	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00214	0.00329	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00213	0.00327	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00213	0.00327	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00208	0.0032	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.00204	0.00313	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00203	0.00311	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00197	0.00302	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00196	0.00302	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.00193	0.00297	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00192	0.00294	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00191	0.00293	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00189	0.0029	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—DLG4—polycystic ovary syndrome	0.00189	0.00289	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00186	0.00286	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00184	0.00282	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00181	0.00278	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00181	0.00278	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.00179	0.00275	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00177	0.00272	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00175	0.00268	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.00173	0.00266	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.00173	0.00266	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00166	0.00255	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00165	0.00254	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00162	0.00249	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00162	0.00248	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00159	0.00244	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.00159	0.00243	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SUOX—polycystic ovary syndrome	0.00159	0.00243	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00157	0.0024	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	0.0015	0.00231	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.00147	0.00226	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00147	0.00225	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00145	0.00223	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00144	0.00221	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.00143	0.00219	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00141	0.00217	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.0014	0.00214	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00138	0.00212	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00135	0.00207	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00135	0.00207	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00133	0.00205	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00133	0.00204	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.0013	0.002	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.0013	0.002	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.0013	0.002	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00129	0.00199	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.00128	0.00196	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00128	0.00196	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TEAD2—polycystic ovary syndrome	0.00125	0.00192	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.00125	0.00192	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00123	0.00189	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00123	0.00188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00123	0.00188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00121	0.00185	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00121	0.00185	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.0012	0.00184	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00119	0.00182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00116	0.00177	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00116	0.00177	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00115	0.00176	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.00114	0.00174	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00111	0.00171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00111	0.00171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00111	0.00171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00108	0.00166	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.00106	0.00163	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.00105	0.00161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00104	0.0016	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00101	0.00155	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SRD5A1—polycystic ovary syndrome	0.000996	0.00153	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000991	0.00152	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000985	0.00151	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000983	0.00151	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—STAR—polycystic ovary syndrome	0.00095	0.00146	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000944	0.00145	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000939	0.00144	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000914	0.0014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000912	0.0014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000901	0.00138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000897	0.00138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000894	0.00137	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000878	0.00135	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000849	0.0013	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMMR—polycystic ovary syndrome	0.000847	0.0013	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00082	0.00126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000815	0.00125	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HSD3B1—polycystic ovary syndrome	0.000808	0.00124	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000799	0.00123	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00079	0.00121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000788	0.00121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00078	0.0012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000778	0.00119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000763	0.00117	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000757	0.00116	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000755	0.00116	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000745	0.00114	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LHB—polycystic ovary syndrome	0.000737	0.00113	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000731	0.00112	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HSD3B2—polycystic ovary syndrome	0.00072	0.00111	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000717	0.0011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000712	0.00109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000709	0.00109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.0007	0.00107	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKR1C1—polycystic ovary syndrome	0.000698	0.00107	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000698	0.00107	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000693	0.00106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000679	0.00104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000664	0.00102	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000657	0.00101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000657	0.00101	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SULT2A1—polycystic ovary syndrome	0.000642	0.000985	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000633	0.000972	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—RRM2—polycystic ovary syndrome	0.000622	0.000954	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000619	0.000949	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000615	0.000944	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—YAP1—polycystic ovary syndrome	0.000599	0.00092	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000597	0.000916	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000581	0.000891	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NAMPT—polycystic ovary syndrome	0.000576	0.000884	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000572	0.000878	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP11A1—polycystic ovary syndrome	0.000569	0.000873	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000568	0.000871	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000566	0.000868	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000565	0.000866	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKR1C3—polycystic ovary syndrome	0.000537	0.000824	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP17A1—polycystic ovary syndrome	0.000529	0.000811	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000528	0.000811	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000515	0.000791	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000488	0.000749	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—INS—polycystic ovary syndrome	0.000485	0.000744	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000481	0.000738	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000471	0.000723	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000469	0.00072	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000469	0.00072	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000468	0.000718	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TH—polycystic ovary syndrome	0.000457	0.000702	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000452	0.000694	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC2A4—polycystic ovary syndrome	0.000445	0.000683	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00044	0.000675	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000429	0.000658	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000426	0.000654	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000424	0.00065	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000419	0.000642	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP19A1—polycystic ovary syndrome	0.000418	0.000642	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000409	0.000628	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000396	0.000608	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000395	0.000607	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000392	0.000602	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000387	0.000594	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000374	0.000574	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GNAS—polycystic ovary syndrome	0.000373	0.000573	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000368	0.000564	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000365	0.00056	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000359	0.000551	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOR1—polycystic ovary syndrome	0.000356	0.000546	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00034	0.000522	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1A1—polycystic ovary syndrome	0.000337	0.000518	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000336	0.000515	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000321	0.000493	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTHFR—polycystic ovary syndrome	0.000314	0.000482	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000305	0.000468	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.0003	0.000461	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000297	0.000456	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000276	0.000424	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000276	0.000424	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000266	0.000409	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000264	0.000405	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000257	0.000395	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000256	0.000393	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARG—polycystic ovary syndrome	0.000255	0.000391	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—POMC—polycystic ovary syndrome	0.000251	0.000386	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—INS—polycystic ovary syndrome	0.00025	0.000384	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000243	0.000373	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000242	0.000371	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000241	0.00037	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000232	0.000357	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000229	0.000351	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000212	0.000326	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000202	0.00031	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000198	0.000304	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00017	0.000261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000166	0.000255	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000148	0.000228	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000143	0.000219	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	0.000142	0.000218	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000137	0.000211	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000137	0.000211	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.00013	0.0002	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000105	0.000161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.97e-05	0.000138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	6.21e-05	9.52e-05	CbGpPWpGaD
